Raloxifene and estrogen effects on quality of life in healthy postmenopausal women: A placebo-controlled randomized trial

Obstetrics and Gynecology

Volumn 96, Issue 3, 2000, Pages 359-365

  Strickler, Ronald ^a   Stovall, Dale W ^b   Merritt, Diane ^c   Shen, Wei ^d   Wong, Mayme ^d   Silfen, Sheryl L ^b  

^a HENRY FORD HOSPITAL   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c BARNES JEWISH HOSPITAL   (United States)

^d ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; PLACEBO; RALOXIFENE;

ADULT; ANXIETY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEAR; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MEMORY; MOOD; MULTICENTER STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SEXUAL BEHAVIOR; SLEEP; SYMPTOMATOLOGY; UNITED STATES;

CLIMACTERIC; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; ESTROGEN RECEPTOR MODULATORS; ESTROGEN REPLACEMENT THERAPY; ESTROGENS, CONJUGATED (USP); FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; QUALITY OF LIFE; RALOXIFENE;

EQUIDAE;

EID: 0034734964     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006250-200009000-00008     Document Type: Article

References (30)

1. Kaufert PA, Gilbert P, Täte R. The Manitoba Project: A reexamination of the link between menopause and depression. Maturitas 1992;14:143-55.
2. Ravnikar VA. Compliance with hormone replacement therapy: Are women receiving the full impact of hormone replacement therapy preventative health benefits? Women's Health Issues 1992;2:75-82.
3. Cagnacci A, Volpe A, Arangino S, Malmusi S, Draetta FP, Matteo ML, et al. Depression and anxiety in climacteric women: Role of hormone replacement therapy. Menopause 1997;4:206-11.
4. Hilditch JR, Lewis J, Ross AH, Peter A, van Maris B, Franssen E, et al. A comparison of the effects of oral conjugated equine estrogen and transdermal estradiol-17 beta combined with an oral progestin on quality of life in postmenopausal women. Maturitas 1996;24: 177-84.
5. Phillips SM, Shenvin BB. Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology 1992; 17:485-95.
6. Greendale GA, Reboussin BA, Hogan P, Barnabei VM, Shumaker S, Johnson S, et al. Symptom relief and side effects of postmenopausal hormones: Results from the Postmenopausal Estrogen/ Progestin Interventions Trial. Obstet Gynecol 1998;92:982-8.
7. Carlson LE, Sherwin BB. Steroid hormones, memory, and mood in a healthy elderly population. Psychoneuroendocrinology 1998;23: 583-603.
8. McKinlay SM. The normal menopause transition: An overview. Maturitas 1996;23:137-45.
9. Kuh DL, Wadsworth M, Hardy R. Women's health in midlife: The influence of the menopause, social factors, and health in earlier life. Br J Obstet Gynaecol 1997;104:923-33.
10. Khovidhunkit W, Shoback DM. Clinical effects of raloxifene hydrochloride in women. Ann Intern Med 1999;130:431-9.
11. Delmas PD, Bjarnason NH, Mitlak BH, Ravoux AC, Shah AS, Huster WJ, et al. Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women. N Engl J Med 1997;337:1641-7.
12. Walsh BW, Kuller LH, Wild RA, Paul S, Farmer M, Lawrence JB, et al. Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women. JAMA 1998;279:1445-51.
13. Ettinger B, Black DM, Mitlak BH, Knickerbocker RK, Nickelsen T, Genant HK, et al. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: Results from a 3-year randomized clinical trial. JAMA 1999;282:637-45.
14. Cummings S, Eckert 5, Krueger K, Grady D, Powles T, Cauley J, et al. The effect of raloxifene on risk of breast cancer in postmenopausal women. JAMA 1999;281:2189-97.
15. Nickelsen T, Lufkin EG, Riggs BL, Cox DA, Crook TH III. Raloxifene hydrochloride, a selective estrogen receptor modulator: Safety assessment of effects on cognitive function and mood in postmenopausal women. Psychoneuroendocrinology 1999;24:11528.
16. Hunter M. The Women's Health Questionnaire: A measure of mid-aged women's perceptions of their emotional and physical health. Psychology and Health 1992;7:45-54.
17. Wiklund I, Berg G, Hammar M, Karlberg J, Lindgren R, Sandin K. Long-term effect of transdermal hormonal therapy on aspects of quality of life in postmenopausal women. Maturitas 1992;14:22536.
18. Goldstein SR, Scheele WH, Rajagopalan SK, VVilkie JL, WaIsh BW, Parsons AK. A 12-month comparative study of raloxifene, estrogen, and placebo on the postmenopausal endometrium. Obstet Gynecol 2000;95:95-103.
19. Wiklund I, Karlberg J, Mattsson LA. Quality of life of postmenopausal women on a regimen of transdermal estradiol therapy: A double-blind placebo-controlled study. Am J Obstet Gynecol 1993; 168:824-30.
20. Guyatt GH, Bombardier C, Tugwell PX. Measuring diseasespecific quality of life in clinical trials. CMAJ 19S6;134:889-95.
21. Matthews KA, Wing RR, Kuller LH, Meilahn EN, Kelsey SF, Costello EJ, et al. Influences of natural menopause on psychological characteristics and symptoms of middle-aged healthy women. J Consult Clin Psychol 1990;58:345-51.
22. Nedstrand E, Wijma K, Lindgren M, Hammar M. The relationship between stress-coping and vasomotor symptoms in postmenopausal women. Maturitas 199S;31:29-34.
23. Matthews K, Cauley J, Yaffe K, Zmuda ]M. Estrogen replacement therapy and cognitive decline in older community women. J Am Geriatr Soc 1999;47:518-23.
24. Panay N, Studd J. Progestogen intolerance and compliance with hormone replacement therapy in menopausal women. Hum Reprod Update 1997;3:159-71.
25. Kaufert P, Boggs PP, Ettinger B, Woods NF, Utian WH. Women and menopause: Beliefs, attitudes, and behaviors. The North American Menopause Society 1997 menopause survey. Menopause 1998;5:197-202.
26. Fugate Woods N, Saver B, Taylor T. Attitudes toward menopause and hormone therapy among women with access to health care. Menopause 199S;5:178-S8.
27. Limouzin-Lamothe MA, Mairon N, Joyce CR, Le Gal M. Quality of life after the menopause: Influence of hormonal replacement therapy. Am J Obstet Gynecol 1994;170:618-24.
28. Barrett-Connor E, Kritz-Silverstein D. Estrogen replacement therapy and cognitive function in older women. JAMA 1993;269:263741.
29. Polo-Kantola P, Portin R, Polo O, Helenius H, Irjala K, Erkkola R. The effect of short-term estrogen replacement therapy on cognition: A randomized, double-blind, cross-over trial in postmenopausal women. Obstet Gynecol 1998;91:459-66.
30. Yaffe K, Sawaya G, Lieberburg I, Grady D. Estrogen therapy in postmenopausal women: Effects on cognitive function and dementia. JAMA 1998;279:688-95.